• November 16, 2022
    Global Mo-99 and I-131 Production Impacted by delay of BR2 Reactor Restarting

    Nuclear Medicine Europe has reported a shortage of molybdenum-99 (Mo-99)/technetium-99m (Tc-99m) through and beyond the third week of November.

    Read More
  • January 26, 2022
    Alert: HFR Outage Will Impact Isotope Supply

    NMEU COMMUNICATION 24 JAN 2022 Z January 26, 2022 On January 24, the Emergency Response Team (ERT) of Nuclear Medicine Europe (NMEu) communicated that there will be a delay in the restart of the HFR Reactor that will impact the supply of Mo-99 and Lu-177 in coming weeks. The delay is due to discovery of […]

    Read More
  • April 16, 2020
    Update on the Radioisotopes Supply

    The Security of Supply Working Group (SoS WG) Emergency Response Team (ERT) held a teleconference on 15 April 2020 to discuss the impact of the COVID-19 pandemic on Mo-99 and other radioisotope production. All organizations again reported that production operations continue normally within adjustments that have been taken against COVID-19, although production is being oriented […]

    Read More
  • December 5, 2017
    Halt to production at NTP Radioisotopes

    There is currently a halt to production at NTP Radioisotopes. The Canadian Association of Radiopharmaceutical Scientists (CARS) would like to assess the impact of this production halt on the Canadian radiopharmaceutical community…

    Read More
  • November 22, 2017
    Halt to production ordered at NTP Radioisotopes by TIMESLIVE

    A halt to production at NTP Radioisotopes‚ a subsidiary of the South African Nuclear Energy Corporation (Necsa)‚ has been ordered after it discovered procedural deviations related…

    Read More
  • September 26, 2017
    Radioisotope supplies stable but still vulnerable

    The IAEA event examined the current supply scenario for molybdenum-99 (Mo-99) and its daughter isotope, technetium-99m (Tc-99m) and alternative production…

    Read More

Join us as a member

Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.